Search Medical Condition
Please enter condition
Please choose location

Stent Clinical Trials

A listing of Stent medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (108) clinical trials

A clinical study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System which was previously approved by the FDA. Patient Inclusion Criteria: >years of age Patients that need a stent in the coronary arteries Patient Exclusion Criteria: Cannot receive the protocol required dual antiplatelet therapy Currently taking warfarin or similar anticoagulant ...

Phase

Humanitarian Use Device - Intracranial artery stenosis - The WingspanTM Stent System and GatewayTM PTA Balloon Catheter have been developed for the treatment of intracranial artery stenosis. Patient Inclusion Criteria: Adults > 40 years old with symptomatic stenosis of one of those intracranial arteries: Internal carotid artery (ICA ), M1 ...

Phase N/A

People with a wide-necked brain aneurysm are asked to participate in a research study being conducted by North Shore-Long Island Jewish Health System.

Phase N/A

Multi center, non-blinded, non-randomized post approval study looking at the long-term performance of the Relay Thoracic Stent Graft System with Plus Delivery System by assessing the rate of aneurysm-related mortality at 5 years post-implant.

Phase N/A

Humanitarian Use for emergent, life-threatening free perforations, aka free contrast extravasations, into the pericardium in native coronary vessels or saphenous vein bypass grafts ≥ 2.75 mm in diameter.

Phase N/A

Cardiovascular disease is the leading cause of morbidity and mortality in industrialized nations, and atherosclerosis has been linked as the chief underlying pathology. Stroke as a result of the atherosclerotic carotid artery disease (CAD) is a common cause of death and a major reason for long-term disability worldwide1. Currently, it ...

Phase N/A

The Wingspan® Stent System with Gateway® Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter was approved in the United States (US) under a Humanitarian Device Exemption (HDE) and received CE Mark in 2005. This study is being conducted to fulfill Food and Drug Administration (FDA) post market safety surveillance requirements

Phase N/A

Do Cobalt Chrome Stent and Paclitaxel-Eluting Stent Have Equivalent Clinical Result in Non-Complex Lesion?

Drug-eluting stent (DES) has been proved to reduced restenosis rate dramatically compared to bare metal stent (BMS). However, the long-term safety of DES is still uncertain. Recent meta-analysis showed that very late stent thrombosis rate was higher in DES group although overall mortality was similar between 2 groups. The safety ...

Phase

Firebird2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent Registry Trial

[Definition and management of adverse event] Adverse event refers to any undesirable clinical event. It may be caused by devices, rapamycin, procedure related complications, or the adjunctive medications (such as aspirin, clopidogrel, ticlopidine, or other anti-platelet agent) used in this study. Self report of adverse events by patients should be ...

Phase N/A